Table 3 HIV disease characteristics of the cases
From: Likelihood of obstructive sleep apnea in people living with HIV in Cameroon – preliminary findings
N | % | |
|---|---|---|
39 | 47.6 | |
Age at diagnosis (years) | ||
Mean ± SD | 32.26 ± 8.94 | |
20–24 | 9 | 23.7 |
≥25 | 29 | 76.3 |
Disease duration since diagnosis | ||
Mean ± SD (months) | 44.61 ± 50.12 | |
≤6 months | 14 | 36.8 |
<6 months | 24 | 63.2 |
CD4 count (count/mm3), Mean ± SD | 410.92 ± 144.90 | |
<350 | 3 | 23.1 |
≥350 | 10 | 76.9 |
WHO disease stage | ||
Stage 1 | 26 | 68.4 |
Stage 2 | 3 | 7.9 |
Stage 3 | 7 | 18.4 |
Stage 4 | 2 | 5.3 |
CDC disease stage | ||
A1 | 11 | 78.6 |
A2 | 1 | 7.1 |
C1 | 1 | 7.1 |
C3 | 1 | 7.1 |
Routine check-ups in last 3 months | ||
Mean ± SD | 1.00 ± 1.33 | |
None | 20 | 54.1 |
At least 1 | 17 | 45.9 |
Patient on HAART | ||
No | 14 | 36.8 |
Yes | 24 | 63.2 |
Compliant to HAART | ||
Yes | 17 | 70.8 |
No | 7 | 29.2 |
HAART duration since onset | ||
Mean ± SD (months) | 47.76 ± 44.71 | |
<6 months | 4 | 23.5 |
≥6 months | 13 | 76.5 |
HAART protocol type | ||
1st line | 13 | 92.9 |
2nd line | 1 | 7.1 |
HIV complications during 3 months preceeding study | ||
At least one | 2 | 5.4 |
None | 35 | 94.6 |
Presence of other concurrent disease | ||
At least one | 5 | 13.5 |
None | 32 | 86.5 |